// Definition
A United States patent titled 'Cannabinoids as Antioxidants and Neuroprotectants,' held by the US Department of Health and Human Services. Filed in 1999 and granted in 2003, it documents cannabinoids' therapeutic effects including neuroprotection and antioxidant properties, directly contradicting Schedule I's claim of 'no accepted medical use.'
// From the Episode
Dr. Mark Scialdone performed a detailed reading of the patent on Hash Church, highlighting that it demonstrates cannabinoids protect against glutamate neurotoxicity and free radical damage through mechanisms unrelated to CB-1 receptors (likely TRPV1). He noted the patent was exclusively licensed to a small company called Canalife, meaning the government collected licensing revenue while other agencies imprisoned people for cannabis. The patent expired in 2019.